Nash Huw M. 4
4 · Stoke Therapeutics, Inc. · Filed Jun 7, 2024
Insider Transaction Report
Form 4
Nash Huw M.
COO & CBO
Transactions
- Award
Employee Stock Option (Right to Buy)
2024-03-27+60,000→ 60,000 totalExercise: $14.17Exp: 2034-03-26→ Common Stock (60,000 underlying) - Award
Restricted Stock Units
2024-03-27+40,000→ 40,000 totalExp: 2028-03-15→ Common Stock (40,000 underlying)
Footnotes (3)
- [F1]The option vested or vests as to 1/48 of the total award on April 15, 2024, with 1/48 vesting on each monthly anniversary thereafter, subject to the reporting person's continued service to the issuer through each vesting date.
- [F2]Each Restricted Stock Unit ("RSU") represents a contingent right to receive one (1) share of the issuer's Common Stock upon settlement.
- [F3]The award vests as to 1/4 of the total award annually beginning on March 15, 2025, subject to the reporting person's continued service to the issuer through each vesting date.